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Dural Sinus Thrombosis in Children With Cancer
Roel E. Reddingius,1 Catherine Patte,1* Dominique Couanet,2 Chantal Kalifa,1 
and Jean Lemerle1
Dural sinus throm bosis (DST) has been  re­
ported  in associa tion  with can ce r  in both adults 
an d  ch ild ren . W e describe  the  seven patients 
seen  w ith  this com plica tion  in ou r centre  b e ­
tw e e n  1981 an d  1995 . D iagnosis  w as c o n ­
firm ed by e ither cerebral CT scanning, MRI or 
ang iography . M edian  age w as 13 years (range 
8 -1 5 ) .  Six patien ts  w e re  boys. Six children w ere  
being  trea ted  for non-H odgkin  lym phom a and  
o n e  for n eu ro b las to m a . Presenting sym ptom s 
w ere  se izures  an d  transient neuro logic  deficit, 
often p re c e d e d  by headaches . The p ro b ab le  
cau se  of DST w as  found  in tw o cases. Tum our 
localisation  in the central nervous system (CNS) 
p ro bab ly  c a u se d  DST in o n e  patien t w ho w as 
tre a te d  for Ki 1 ly m p h o m a. D ehydra tion  in 
c o m b in a t io n  with a poo r genera l co n d itio n  
se e m e d  to be  the  cau se  of DST in the patient 
w ith  neu rob las to m a . In five ch ildren  with stage
ill or IV non-H odgk in  lym phom a (three lym­
p h o b la s t i c  ly m p h o m a ;  tw o  B u rk it t 's  ly m ­
phom a), etiology rem ained  unknow n. In these 
children , DST o ccu rred  early in the course  of 
therapy. The m edian  interval be tw een  start of 
ch em o th e rap y  an d  o n se t of sym ptom s w as 19 
days (range 8 -40 ). N o child had received L- 
asparaginase. Prognosis was favourable, with 
sy m p to m s c o m p le te ly  d isa p p e a r in g  w ith o u t 
therapy  within 1 to 5 days. The inc idence  of 
DST in p a t ie n ts  w ith  a d v a n c e d  stage n o n - 
H odgkin lym phom a during  induction and  c o n ­
solidation w as ca lcu la ted  to be be low  3%. W e  
co n c lu d e  that DST is rarely d iagnosed  in ch il­
dren with cancer. O ccu rren ce  during the initial 
ph ase  o f  therapy  for non-H odgkin  lym phom a is 
associa ted  with a ben ign  prognosis. Med. Pedi- 
atr. O ncoL  2 9 :2 9 6 -3 0 2 ,  1997.
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INTRODUCTION
The occurrence of dural sinus thrombosis (DST) has 
been reported in patients with cancer [1,2]. In children 
the occurrence of DST has been predominantly described 
in patients with leukaemia [3-6], The presumed etiology 
is the hypercoagulability due to the asparaginase-induced 
antithrombin III deficiency [7]. Dural sinus thrombosis 
was also established in children treated for non-Hodgkin 
lymphoma, even in those not treated with L-asparaginase 
[8]. The objective of this retrospective study was to study 
this complication in a population of children treated for 
solid tumours.
MATERIALS AND METHODS
The medical files were studied of all children in whom 
treatment of a malignancy was complicated by DST be­
tween 1980 and 1995. All radiographs were reviewed. 
Patients were only admissible if the diagnosis was con­
firmed by one or more radiological studies. This could be 
either a cerebral CT scan showing spontaneous hyper­
density of the sinuses or the empty delta sign after con­
trast administration, an MRI showing abnormal signal 
intensities of the sinuses with loss of high signal intensity 
on fast spin-echo images or an angiography showing oc­
clusion [9,10].
RESULTS
The study population consisted of seven children. Six 
of them were boys. The median age of these children was 
13 years (range 8-15). Six out of seven children (patient 
nos. 1-6) had a non-Hodgkin lymphoma and one child 
suffered from neuroblastoma. Clinical data of all patients 
are given in Table I.
The main presenting symptom in all patients was die 
occurrence of seizures. Although all children eventually 
had convulsions, this was the first symptom in three chil­
dren. While they were confined to one day in the major­
ity of the patients, recurrence during a five-day period 
was seen in one of them. Seizures were focal in five out 
of seven children. In three children, a severe headache 
was the primary complaint. Transient neurologic deficit 
occurred in four children. The median total duration of 
symptoms was 2 days (range 1-50),
The diagnosis of DST was confirmed only by cerebral 
CT scan in three cases, by CT in combination with an­
giography in two cases, by MRI in combination with
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TABLE I. Clinical Data of the Studied Patients: Patient Number, Sex, Age, Year of Diagnosis, Diagnosis, Drugs Received During the Last Chemotherapy Course Before Onset 
of Symptoms, Day of Onset of Symptoms, Symptoms, Duration of Symptoms and Neuroimaging, Including the Day the Investigation was Performed
Patient
no. Sex
Age
in
years Year Diagnosis
Protocol and drugs 
received during 
chemotherapy course 
before onset of 
symptoms Day
Symptoms (day 1 =  
start of chemotherapy)
Duration
of
symptoms Day
Neuro imaging 
(day 1 =  beginning of symptoms)
1 M 9 1985 lymphoblastic LMT81 [12]: CPMa; 10 hemiconvulsions of the 24 hours 1 CT +a postcontrast enhancement in right frontoparietal
lymphoma stage VCRa; PREDa; left side of the body area
IV IT-MTX3 (induction) 14 CT + frontal lesion persists; empty delta sign,
consistent with sagittal sinus thrombosis
2 M 14 1989 lymphoblastic LMT81 [12]: HD-MTXa; 37 headaches; focal seizures 48 hours 3 CT + empty delta sign, consistent with sagittal sinus
lymphoma stage IT-MTX; 6-TGa; of the left side of the thrombosis
IV CYT-ARAa face and the left arm 4 angio sagittal sinus thrombosis + partial thrombosis
(consolidation) of lateral sinuses
3 M 12 1987 lymphoblastic LMT81 [12]: CPM; 8 hemiconvulsions and 5 days -6 CT + normal
lymphoma stage VCR; PRED; IT-triplea hemiplegia of the left 2 CT + spontaneous hyperdensity in right parietal area
IV (with CNS (induction) side of the body 6 angio normal
involvement) idem + HD-MTX 19 reappearance of 48 hours 2 CT + hypodensity in right parietal area; spontaneous
symptoms 11 days hyperdensity of the sagittal sinus + positive
later: bizarre delta sign after contrast, consistent with
* sensations of the right sagittal sinus thrombosis
side of the body and 4 angio complete sagittal sinus thrombosis and partial
right hemiparesis right lateral sinus thrombosis
9 MRI sagittal sinus thrombosis; hemorrhage in the
right parietal area
4 M 15 1983 Burkitt’s LMB81 [14]: CPM; 19 headaches; generalized2 5 days 2 CT + nonconclusive
lymphoma stage VCR; PRED; convulsion 14 CT + delta sign positive, consistent with sagittal sinus
m HD-MTX; IT-MTX; thrombosis
ADRIA3 (COPADM1) 19 angio partial thrombosis of the superior sagittal sinus
5 M 13 1993 Burkitt’s LMB89 [13]: CPM; 40 hemiconvulsions and 48 hours 1 CT + spontaneous hyperdensity of the sagittal sinus +
lymphoma stage VCR; PRED; hemiparesis of the positive delta sign after contrast, consistent
n i HD-MTX; IT-MTX; right side of the body; with sagittal sinus thrombosis
ADRIA (COPADM2) complete amaurosis
6 F 15 1985 Ki 1 lymphoma COPAD [11]: CPM; 13 headaches; diplopia with until death 12 CT + hypodense lesion in the left cerebellum
stage III VCR; PRED; ADRIA dysfunction of the 50 days 20 angio partial thrombosis of the left lateral sinus
right abducens nerve; later 32 CT + multiple hyperdense lesions in cerebrum and
gradually worsening cerebellum
condition with 37 CT + an increase in number and extent of these
hemiconvulsions of the lesions
left side of the body 39 MRI sagittal sinus thrombosis
just prior to death 46 angio thrombosis of risht and left lateral sinus and
partial thrombosis of the sagittal sinus
7 M 8 1990 neuroblastoma 5FU; folic acid b change of conscience 1 month 1 CT multiple hypodense areas in the two parietal
with des orientation in lobes; spontaneous hyperdensity of the
time and space; sagittal sinus, consistent with sagittal sinus
generalized convulsion thrombosis
a6-TG, 6-thioguanine; ADRIA, adriamycine; CPM, cyclophosphamide; CT +, CT scan, including contrast administration; CYT-ARA, cytosine-arabinoside: IT-triple, intrathecal injections with
MTX, hydrocortisone and cytosine-arabinoside; MTX, methotrexate (IT, intrathecal; HD, high dose); PRED, prednisone; VCR, vincristine.
bIn patient no. 7, symptoms appeared during a period of intensive chemotherapy, 3 years after initial diagnosis and 11 months after recurrence of the disease.
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angiography in one case and by all three investigations in 
one case. In two children, in whom diagnosis was even­
tually confirmed by CT scan, initial CT scans did not 
establish the presence of DST. In the four children in 
whom angiography was performed, CT scanning had 
failed to confirm the diagnosis in one case. In this case, 
an MRI was realized, affirming diagnosis. There were no 
cases with either a positive CT or MRI in combination 
with a negative angiography.
A lumbar puncture was performed in five children. In 
patient no. 6, abnormalities were found consistent with 
meningitis. This patient is discussed later. In the other 
four, results were normal or practically normal, yielding 
only a slightly elevated protein content (range 0.29-0.66
g/L)-
Simple haemostatic studies, including assessment of 
activated thromboplastin time, prothrombin time and fi­
brinogen levels, were performed in six children, disclos­
ing no major abnormalities. In three children, more ex­
tensive studies established the absence of a deficiency of 
protein C, protein S or antithrombin III.
The probable cause of DST could be established in 
two children, patient nos. 6 and 7. In patient no. 6 , neu­
rologic symptoms appeared 13 days after start of chemo­
therapy. Cerebrospinal fluid was consistent with menin­
gitis, with high cell counts and low levels of glucose. 
Cytological studies showed a predominance of polymor­
phonuclear neutrophils, but no evidence of malignancy. 
However, bacteriological studies remained negative. 
Neuro-imaging revealed multiple hyperdense lesions in 
cerebrum as well as cerebellum. These lesions were sus­
pected to be localisations of the disease in the brain. The 
chemotherapeutic regimen was continued [11]. Dural si­
nus thrombosis was established later in the course of the 
disease. It was decided to treat the patient with heparin. 
Subsequently, the clinical condition of the patient dete­
riorated and a CT scan demonstrated a cerebral haema- 
toma. The patient died. A t autopsy, central nervous sys­
tem (CNS) localisation of Ki 1 lymphoma was estab­
lished with extensive perivascular infiltration. In this 
patient, it seems likely that DST was caused by the pres­
ence of tumour cells in or in the vicinity of the sinus. 
Patient no. 7 developed DST during a period of intensive 
chemotherapy for recurrent neuroblastoma, 3 years after 
initial diagnosis. Dehydration in combination with a poor 
general condition as a result of treatment may explain the 
occurrence of DST in this patient. There was a complete 
clinical and radiological recovery from DST in this pa­
tient.
The cause of DST was not clear in five children with 
lymphoma (patient nos. 1-5). One of these patients, pa­
tient no. 3, had initial CNS disease. Since cerebrospinal 
fluid counts had returned to normal on day 6 of the 
induction phase and since cerebral CT scanning showed 
no abnormalities, it seems unlikely that sinus thrombosis
was caused by CNS localisation of tumour cells. In the 
other four children, there was no evidence of CNS dis­
ease. These five children were treated by one of the pub­
lished lymphoma protocols of the French Pediatric On­
cology Society [12-14] or a subsequent protocol. All 
children had advanced disease, either stage IV lympho­
blastic lymphoma or stage III Burkitt’s lymphoma. None 
of them suffered from thrombocytopenia or thrombocy­
tosis. Apart from the occurrence of DST, the treatment 
was tolerated well in all children. No patient had received 
L-asparaginase. They had all displayed a rapid disappear­
ance of tumour and were in complete remission at time of 
onset of symptoms related to DST. Symptoms appeared 
early in the course of chemotherapy treatment. The me­
dian interval between start of chemotherapy and onset of 
symptoms was 19 days (range 8-40). The duration of 
symptoms was always short, with a maximum of five 
days. These patients all recovered completely, clinically 
as well as radiologically, from DST.
During the study period, 307 patients were treated for 
stage III or IV non-Hodgkin lymphoma in our centre and 
registered in one of the protocols of the French Pediatric 
Oncology Society. Amongst these were five patients with 
reported convulsions in the induction or consolidation 
phase in whom a diagnosis of DST was not made. In 
three of them, convulsions were attributed to another 
cause. One child had a cerebral abscess; in one child 
administration of high dose methotrexate was thought to 
have caused the convulsions and one child with fever was 
thought to have had a febrile convulsion. In two children, 
no cause was found. In one of them, DST was assumed 
to have caused the convulsions, but imaging studies 
failed to confirm this. In view of this information, the 
incidence of symptomatic DST during the induction and 
consolidation phase in patients with advanced stage non- 
Hodgkin lymphoma probably lies between 1% and 3%,
DISCUSSION
Dural sinus thrombosis in children is associated with 
multiple etiologies such as dehydration, infections, hae- 
matological diseases and disorders of coagulation [15- 
23], In many cases the cause is unknown,
In adult series of patients suffering from DST, malig­
nancy is a rare cause [24]. Obstruction of venous drain­
age can be due to invasion or compression of sinuses by 
the neoplasm [25]. Thrombosis as a “ paraneoplastic” 
phenomenon is another possibility [1],
Thrombosis of the sagittal sinus has been reported in 
children with cancer [3-6,8,26,27]. The first observa­
tions were made in children with leukaemia [3-6]. This 
complication can be ascribed to hypercoagulability due 
to the asparaginase-induced antithrombin III deficiency 
[7]. Legrand et al. [8] reported four children in whom 
DST occurred early in the course of treatment for non-
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Hodgkin lymphoma. Only two of these children had been 
treated with L-asparaginase.
The number of new patients with solid tumours seen 
in our centre is approximately 300 per year» In the pres­
ent study, we have reviewed all cases of DST diagnosed 
in a 15-year period. We have established that DST is a 
very rare event. Six out of seven cases occurred in chil­
dren who were treated for non-Hodgkin lymphoma; one 
child was treated because of relapsing neuroblastoma. 
The most important presenting problem was either a se­
vere headache or sudden convulsions. Neurologic defi­
cits, for instance, hemiplegia, also occurred regularly. 
Symptoms usually disappeared within a few days.
In our patients, diagnosis was usually confirmed by a 
cerebral CT scan. It must be noted that diagnosis could 
not be established on the initial scan in two cases, while 
repeat of the investigation after 2 weeks did. In fact, CT 
scanning was repeated because the symptoms were 
thought to be typical of DST, prompting the clinician to 
ask for a repeat investigation. Symptoms had by then 
usually disappeared. This implies that diagnosis may 
have been missed in some patients with a less clear 
symptomatology, in whom repeating a CT scan seemed 
unnecessary. In one patient with a positive angiography, 
CT scanning repeatedly failed to reveal DST. The poor 
quality of CT scans in the earlier years is probably partly 
responsible for this. An MRI was performed in two chil­
dren only; in one of whom it seemed superior to CT 
scanning.
Radiological proof of DST can be obtained in a num-
Fig. 1. CT scan of patient number 2, made 3 days after onset of 
symptoms, clearly showing the empty delta sign after contrast admin­
istration (arrow),
Hodgkin lymphoma during the induction or consolida­
tion phase seems to be below 3%.
It does not seem likely that a specific chemotherapeu-
ber of ways. The first choice method seems to be cerebral tic dmg wag responsible for the evenL None of the chil
CT scanning. A spontaneous hypeidensity of the sinus (jren jn s u^cjy received L-asparaginase. Furthermore,
can be observed, whereas the thrombus itself can be vi- the problems did not seem t0 occur following the admin-
sualized as the so-called empty delta sign after contrast istration of any other specific drug. Additionally, the
administration [10]. This is illustrated in Figure L  Mag- drugs that were used are also used for the treatment of
netic resonance imaging is said to be more sensitive than other malignancies, whereas the occurrence of DST
CT scanning [9]. Various abnormal signal intensities of seems to occur almost exclusively in patients treated for
the sinuses on either T l-  or T2-weighted images can be lymphoma. The occurrence of DST in children treated
seen, depending on the time relapsed between onset of for lymphoma has previously been described by Legrand
thrombosis and imaging (see Fig. 2). Furthermore, ab- et a l  [8]. Only two out o f four children in their study had
sence of bloodflow in the sinuses results in loss of hy- received L-asparaginase.
persignal on fast spin-echo images of occluded sinuses. Hypercoagulation as a cause of DST remains a pos-
With the improvement of the quality of CT scans and the sibility. A “ hypercoagulable state” has been described
increase in availability of MR angiography, the use of in children with leukaemia and solid tumours [28], If  not
angiography will decrease in the future (see Fig. 3). caused by L-asparaginase or another drug, it may be
The etiology of DST is not evident in most of our caused by some agent released by the tumour itself. In
patients. Although CNS localisation of the malignancy fact, initial tumour burden was relatively high, since all
was the probable cause in one and dehydration in an- patients had advanced disease. Tumour lysis in the period
other, the reason was not known in the remaining five preceding sinus thrombosis must have been extensive,
patients. These patients were all treated because of stage 
III or IV non-Hodgkin lymphoma. Even if it is taken into 
account that the diagnosis of DST is sometimes missed in
since all patients were in remission when DST occurred 
within 40 days after start of therapy. Possibly procoagu­
lant factors were released with the breakdown of tumour
patients with a short episode of convulsions, the inci- cells. In this case, one would also expect the occurrence 
dence of DST in patients with advanced stage non- of thrombotic events at other sites of the body in children
300 Reddingi us et al.
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Fig. 2. MRI scan of patient number 3, made 9 days after onset of 
symptoms. A: Sagittal T1 -weighted image, clearly showing exten­
sive hyperintense signal of the entire sagittal sinus (arrows). B: 
Axial T2-weighted image showing hyperintense signal emerging 
from the thrombus in the sinus (arrow) and haemorrhage in the 
right parietal lobe (arrowhead).
treated for non-Hodgkin lymphoma. This, however, has the fibrinolytic system also remains possible, because
not been observed by us. The simple haemostatic studies studies in this direction were not performed in any pa-
that were perform ed in most children in this study do not tient.
exclude abnormalities of coagulation. A hypofunction of It could also be hypothesized that local problems in or
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